Gift or transfer — classified separately from trades.
Joseph W Laplume is EVP, Corp Strategy & Develop at Charles River Laboratories. OQRO lists 10 transactions filed with the SEC under this name, the latest on Aug 11, 2026, each linked to the official Form 4.
EVP, Corp Strategy & Develop
Disclosures on record
10
Companies involved
1
1 buy, median -11.5% vs S&P 500, beat it 0 of 1 time.
Average -11.5% vs S&P 500. Each buy is one disclosure of open-market purchases in one company on one filing date, filed Mar 4, 2026 to Mar 4, 2026, measured from the first close after the filing. Past results, not a forecast.
Gift or transfer — classified separately from trades.
Compensation award — excluded from discretionary-purchase analysis.
Routine share withholding; mechanical by default.
Routine share withholding; mechanical by default.
Routine share withholding; mechanical by default.
Routine share withholding; mechanical by default.
Stock since the trade +76.9% · S&P 500 +13.9% · to Oct 5
Charles River Laboratories's Corp Strategy & Develop paid $4.4K out of pocket for Charles River Laboratories shares.
Compensation award — excluded from discretionary-purchase analysis.
Routine share withholding; mechanical by default.
Stock since the trade +92.0% · S&P 500 +20.1% · to Oct 5
Charles River Laboratories's Corp Strategy & Develop sold $65K of Charles River Laboratories shares. Nobody planned it ahead of time.